In vitro studies of BRCA1-related breast cancers appear to be particularly susceptible to platinum-based drugs chemotherapy, which could be relevant by extrapolation to the treatment of TNBCs [4, 5]. The gene discussed is BRCA1; the disease is breast carcinoma.